Remdesivir is an antiviral that was developed to treat Ebola, a haemorrhagic fever caused by the Ebola virus. - File photo
TOKYO (The Japan News/ANN): Remdesivir, an antiviral drug found to have an effect on infections with the new coronavirus, will likely gain special approval in Japan after a Cabinet decision was made Saturday (May 2) obtaining the approval of each minister in turn to revise a government ordinance.
The drug developed by US pharmaceutical company Gilead Sciences, Inc could be approved as soon as Thursday (May 7). This would make it the first commonly available drug in Japan for treating Covid-19, the disease caused by the new coronavirus.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
